Co-Creator of Force Works for Marvel, Tom Tenney, artist on Deathstroke, DC Showcase, Iron Man, Robotech and many more, asks ...
Use of CT is proven to save lives in patients eligible for lung cancer screening, which includes most patients with COPD, said Barr, professor of medicine and epidemiology at Columbia University ...
GlobalData on MSN
AstraZeneca’s novel COPD drug secures double win in Phase III
GD analyst, Vinie Varkey notes that tozorakimab could capture a "significant patient share" as an add-on therapy in COPD.
AstraZeneca shares were up about 3.5% Friday after the company said its drug for COPD, a deadly lung disease often caused by smoking, slowed patients' symptoms in two large trials. The drug, ...
Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.
AstraZeneca jumps 4% after COPD drug wins Phase 3 trials. Tozorakimab success seen as rare win in tough COPD drug race. Strong trial data boosts AstraZeneca’s long-term revenue outlook. Shares of ...
The rate of new chronic obstructive pulmonary disease (COPD) cases decreased from 2001 to 2020, although the prevalence of COPD has increased.
Top-line results from the OBERON and TITANIA trials showed that tozorakimab reduced the annualised rate of moderate-to-severe ...
The Ombudsman has upheld a complaint from residents over the delivery of care changes at a Falkirk housing complex ...
Select your location to view local American Lung Association events and news near you.
Whatever the reasons, AstraZeneca has emerged as the first IL-33 player to show consistent efficacy. Sanofi and Regeneron reported one hit and one miss in their phase 3 itepekimab program. Roche ...
Patients with respiratory conditions, such as asthma and COPD, are being encouraged to use apps to manage their symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results